Companies House 15030760 2025-07-31 2025-07-31 2024-08-01 false iso4217:GBP xbrli:pure 15030760 2023-07-26 2024-07-31 15030760 2025-07-31 15030760 2024-08-01 2025-07-31 15030760 2024-07-31 15030760 curr:PoundSterling 2024-08-01 2025-07-31 15030760 uk-bus:CompanyLimitedByGuarantee 2024-08-01 2025-07-31 15030760 uk-bus:FRS102 2024-08-01 2025-07-31 15030760 uk-bus:AuditExempt-NoAccountantsReport 2024-08-01 2025-07-31 15030760 uk-bus:FullAccounts 2024-08-01 2025-07-31 15030760 uk-bus:RegisteredOffice 2024-08-01 2025-07-31 15030760 uk-bus:Director1 2024-08-01 2025-07-31 15030760 uk-bus:Director2 2024-08-01 2025-07-31 15030760 uk-bus:Director3 2024-08-01 2025-07-31 15030760 uk-bus:Director4 2024-08-01 2025-07-31 15030760 uk-bus:Director5 2024-08-01 2025-07-31 15030760 uk-bus:Director6 2024-08-01 2025-07-31 15030760 uk-bus:Director7 2024-08-01 2025-07-31 15030760 uk-bus:Director8 2024-08-01 2025-07-31 15030760 uk-bus:Director9 2024-08-01 2025-07-31 15030760 uk-bus:Director10 2024-08-01 2025-07-31 15030760 uk-bus:Director11 2024-08-01 2025-07-31 15030760 uk-bus:Director12 2024-08-01 2025-07-31 15030760 uk-bus:Director13 2024-08-01 2025-07-31 15030760 uk-bus:Director14 2024-08-01 2025-07-31 15030760 uk-bus:Director15 2024-08-01 2025-07-31 15030760 uk-bus:Director16 2024-08-01 2025-07-31 15030760 uk-bus:Director17 2024-08-01 2025-07-31 15030760 uk-bus:Director18 2024-08-01 2025-07-31 15030760 uk-bus:Director19 2024-08-01 2025-07-31 15030760 uk-bus:Director20 2024-08-01 2025-07-31 15030760 uk-bus:Director21 2024-08-01 2025-07-31 15030760 uk-bus:CompanySecretary1 2024-08-01 2025-07-31 15030760 core:AfterOneYear 2025-07-31 15030760 core:AfterOneYear 2024-07-31 15030760 core:WithinOneYear 2025-07-31 15030760 core:WithinOneYear 2024-07-31 15030760 core:WithinOneYear 2024-08-01 2025-07-31 15030760 core:AfterOneYear 2025-07-31 15030760 core:AfterOneYear 2024-07-31 15030760 core:AfterOneYear 2024-08-01 2025-07-31 15030760 core:ShareCapital 2025-07-31 15030760 core:ShareCapital 2024-07-31 15030760 core:SharePremium 2025-07-31 15030760 core:SharePremium 2024-07-31 15030760 core:OtherReservesSubtotal 2025-07-31 15030760 core:OtherReservesSubtotal 2024-07-31 15030760 core:RevaluationReserve 2025-07-31 15030760 core:RevaluationReserve 2024-07-31 15030760 core:RetainedEarningsAccumulatedLosses 2025-07-31 15030760 core:RetainedEarningsAccumulatedLosses 2024-07-31 15030760 1 2024-08-01 2025-07-31 15030760 2 2024-08-01 2025-07-31 15030760 3 2024-08-01 2025-07-31 15030760 core:LandBuildings 2024-08-01 2025-07-31 15030760 core:LandBuildings 2025-07-31 15030760 core:LandBuildings 2023-07-26 2024-07-31 15030760 core:LandBuildings 2024-07-31 15030760 core:PlantMachinery 2024-08-01 2025-07-31 15030760 core:PlantMachinery 2025-07-31 15030760 core:PlantMachinery 2023-07-26 2024-07-31 15030760 core:PlantMachinery 2024-07-31 15030760 core:FurnitureFittingsToolsEquipment 2024-08-01 2025-07-31 15030760 core:FurnitureFittingsToolsEquipment 2025-07-31 15030760 core:FurnitureFittingsToolsEquipment 2023-07-26 2024-07-31 15030760 core:FurnitureFittingsToolsEquipment 2024-07-31 15030760 core:OfficeEquipment 2024-08-01 2025-07-31 15030760 core:OfficeEquipment 2025-07-31 15030760 core:OfficeEquipment 2023-07-26 2024-07-31 15030760 core:OfficeEquipment 2024-07-31 15030760 core:Vehicles 2024-08-01 2025-07-31 15030760 core:Vehicles 2025-07-31 15030760 core:Vehicles 2023-07-26 2024-07-31 15030760 core:Vehicles 2024-07-31 15030760 core:NetGoodwill 2024-08-01 2025-07-31 15030760 core:NetGoodwill 2025-07-31 15030760 core:NetGoodwill 2023-07-26 2024-07-31 15030760 core:NetGoodwill 2024-07-31 15030760 core:IntangibleAssetsOtherThanGoodwill 2024-08-01 2025-07-31 15030760 core:IntangibleAssetsOtherThanGoodwill 2025-07-31 15030760 core:IntangibleAssetsOtherThanGoodwill 2023-07-26 2024-07-31 15030760 core:IntangibleAssetsOtherThanGoodwill 2024-07-31

# RESEARCH FOR HEALTH CIC

## Company limited by guarantee

## Company Registration Number:
15030760 (England and Wales)

## Unaudited statutory accounts for the year ended 31 July 2025

## Period of accounts

## Start date: 1 August 2024

## End date: 31 July 2025

# RESEARCH FOR HEALTH CIC

## Contents of the Financial Statements

for the Period Ended 31 July 2025

Directors report |
Balance sheet |
Additional notes |
Community Interest Report |

# RESEARCH FOR HEALTH CIC

Directors' report period ended 31 July 2025

The directors present their report with the financial statements of the company for the period ended 31 July 2025

Directors

The director shown below has held office during the whole of the period from
1 August 2024 to 31 July 2025

Andrew Smith

The above report has been prepared in accordance with the special provisions in part 15 of the Companies Act 2006

This report was approved by the board of directors on
1 April 2026

And signed on behalf of the board by:
Name: Andrew Smith
Status: Director

# RESEARCH FOR HEALTH CIC

## Balance sheet

As at 31 July 2025

| Notes | 2025 | 2024
--- | --- | --- | ---
|  | £ | £
Fixed assets
Intangible assets: |  | 0 | 0
Tangible assets: |  | 0 | 0
Investments: |  | 0 | 0
Total fixed assets: |  | 0 | 0
Current assets
Stocks: |  | 0 | 0
Debtors: |  | 0 | 0
Cash at bank and in hand: |  | 0 | 0
Investments: |  | 0 | 0
Total current assets: |  | 0 | 0
Prepayments and accrued income: |  | 0 | 0
Creditors: amounts falling due within one year: |  | 0 | 0
Net current assets (liabilities): |  | 0 | 0
Total assets less current liabilities: |  | 0 | 0
Creditors: amounts falling due after more than one year: |  | 0 | 0
Provision for liabilities: |  | 0 | 0
Accruals and deferred income: |  | 0 | 0
Total net assets (liabilities): |  | 0 | 0
Members' funds
Profit and loss account: |  | 0 | 0
Total members' funds: |  | 0 | 0

The notes form part of these financial statements

# RESEARCH FOR HEALTH CIC

## Balance sheet statements

For the year ending 31 July 2025 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The directors have chosen not to file a copy of the company's profit and loss account.

This report was approved by the board of directors on 1 April 2026
and signed on behalf of the board by:

Name: Andrew Smith
Status: Director

The notes form part of these financial statements

# RESEARCH FOR HEALTH CIC

## Notes to the Financial Statements

for the Period Ended 31 July 2025

- ## 1. Accounting policies

  Basis of measurement and preparation

  These financial statements have been prepared in accordance with the provisions of Section 1A (Small Entities) of Financial Reporting Standard 102

# RESEARCH FOR HEALTH CIC

## Notes to the Financial Statements

for the Period Ended 31 July 2025

- ## 2. Employees

  | 2025 | 2024
  --- | --- | ---
  Average number of employees during the period | 1 | 1

  This is the director

# COMMUNITY INTEREST ANNUAL REPORT

### RESEARCH FOR HEALTH CIC

### Company Number: 15030760 (England and Wales)

### Year Ending: 31 July 2025

Company activities and impact

The company has not traded in the last financial year, although did submit a grant application for a project which was unsuccessful.

Consultation with stakeholders

No consultation with stakeholders

Directors' remuneration

No remuneration was received

Transfer of assets

No transfer of assets other than for full consideration

This report was approved by the board of directors on
1 April 2026

And signed on behalf of the board by:
Name: Andrew Smith
Status: Director